Black Rock Inc. Blueprint Medicines Corp Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Black Rock Inc. holds 6,647,297 shares of BPMC stock, worth $691 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
6,647,297
Previous 6,447,461
3.1%
Holding current value
$691 Million
Previous $612 Million
17.14%
% of portfolio
0.02%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding BPMC
# of Institutions
352Shares Held
60.3MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$695 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$560 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$412 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$287 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL1.67MShares$174 Million0.4% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.21B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...